Top Markets
Coin of the day
CytoMed Therapeutics Limited CytoMed Therapeutics Limited

CytoMed Therapeutics Limited

GDTC
शेयरों में रैंक #32327
CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical... CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR) specifically targeting natural killer group 2D ligands, designed to boost their capacity to destroy cancer cells. Beyond its lead candidate, CytoMed is also advancing iPSC-gdNKT, which utilizes induced pluripotent stem cells (iPSCs) to generate a novel hybrid cell combining properties of both gamma delta T cells and natural killer cells. Additionally, the company is developing CTM-GDT, an immunotherapy consisting of expanded gamma delta T cells that leverages their innate, broad-spectrum recognition system to identify and address diverse cancer types.
शेयर मूल्य
$0.88
अंतिम समन्वयन: 2026-08-17
मार्केट कैप
$10.41M
बदलाव (1 दिन)
-7.26%
बदलाव (1 वर्ष)
-50.56%
देश
SG
व्यापार CytoMed Therapeutics Limited (GDTC)

श्रेणी

CytoMed Therapeutics Limited (GDTC) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $0.84 (2026-08-01 को)

दिन का सबसे निम्न समापन मूल्य: $3.48 (2023-04-01 को)
CytoMed Therapeutics Limited के स्टॉक मूल्य का इतिहास 2023 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) -14.06%
2025 -41.13%
2024 -30.38%
2023 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$515.58 32.24%
US
$992.01 50.00%
NL
$736.64 6.99%
CH
$1.07K -6.01%
KR
$255.50 12.02%
BE